Advances in mRNA and other vaccines against MERS-CoV-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Advances in mRNA and other vaccines against MERS-CoV

Published:2021-11 Issue: Volume: Page:
ISSN:1931-5244
Container-title:Translational Research
language:en
Short-container-title:Translational Research

Author:

Tai Wanbo,Zhang Xiujuan,Yang Yang,Zhu Jiang,Du Lanying

Funder

National Institutes of Health

Publisher

Elsevier BV

Subject

Biochemistry (medical),Public Health, Environmental and Occupational Health,General Medicine,Physiology (medical)

Reference131 articles.

1. Subunit vaccines against emerging pathogenic human coronaviruses;Wang;Front Microbiol,2020

2. An overview of Middle East respiratory syndrome coronavirus vaccines in preclinical studies;Zhang;Expert Rev Vaccines,2020

3. Therapeutic antibodies and fusion inhibitors targeting the spike protein of SARS-CoV-2;Jiang;Expert Opin Ther Targets,2021

4. Current advancements and potential strategies in the development of MERS-CoV vaccines;Zhang;Expert Rev Vaccines,2014

5. The spike protein of SARS-CoV–a target for vaccine and therapeutic development;Du;Nat Rev Microbiol,2009

Cited by 19 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Cold-adapted live attenuated MERS-CoV vaccine strain remains attenuated in mice after multiple passages in Vero cells at 37 °C;Archives of Microbiology;2024-09-06

2. Dissecting humoral immune responses to an MVA-vectored MERS-CoV vaccine in humans using a systems serology approach;iScience;2024-08

3. A dual-targeting approach using a human bispecific antibody against the receptor-binding domain of the Middle East Respiratory Syndrome Coronavirus;Virus Research;2024-07

4. A Unique mRNA Vaccine Elicits Protective Efficacy against the SARS-CoV-2 Omicron Variant and SARS-CoV;Vaccines;2024-06-01

5. Nanocarriers of antigen proteins for vaccine delivery;International Journal of Pharmaceutics;2024-06

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3